NSTGQ vs. GENE, CELZ, TTNP, BCDA, FRTX, ONVO, TCON, CHRO, PALI, and ALBT
Should you be buying NanoString Technologies stock or one of its competitors? The main competitors of NanoString Technologies include Genetic Technologies (GENE), Creative Medical Technology (CELZ), Titan Pharmaceuticals (TTNP), BioCardia (BCDA), Fresh Tracks Therapeutics (FRTX), Organovo (ONVO), TRACON Pharmaceuticals (TCON), Chromocell Therapeutics (CHRO), Palisade Bio (PALI), and Avalon GloboCare (ALBT). These companies are all part of the "biological products, except diagnostic" industry.
Genetic Technologies (NASDAQ:GENE) and NanoString Technologies (NASDAQ:NSTGQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.
Genetic Technologies has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, NanoString Technologies has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.
In the previous week, Genetic Technologies had 11 more articles in the media than NanoString Technologies. MarketBeat recorded 12 mentions for Genetic Technologies and 1 mentions for NanoString Technologies. Genetic Technologies' average media sentiment score of 0.00 beat NanoString Technologies' score of -0.19 indicating that NanoString Technologies is being referred to more favorably in the news media.
Genetic Technologies has a net margin of 0.00% compared to Genetic Technologies' net margin of -102.44%.
0.6% of Genetic Technologies shares are owned by institutional investors. Comparatively, 76.8% of NanoString Technologies shares are owned by institutional investors. 6.5% of Genetic Technologies shares are owned by insiders. Comparatively, 3.1% of NanoString Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Genetic Technologies has higher earnings, but lower revenue than NanoString Technologies.
Genetic Technologies received 161 more outperform votes than NanoString Technologies when rated by MarketBeat users.
Summary
Genetic Technologies beats NanoString Technologies on 8 of the 11 factors compared between the two stocks.
Get NanoString Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSTGQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NSTGQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NSTGQ vs. The Competition
NanoString Technologies Competitors List
Related Companies and Tools
